Works matching IS 09615423 AND DT 2020 AND VI 29 AND IP 4


Results: 25
    1
    2
    3
    4

    Phase III study to evaluate patient's preference of subcutaneous versus intravenous trastuzumab in HER2‐positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012‐07).

    Published in:
    European Journal of Cancer Care, 2020, v. 29, n. 4, p. 1, doi. 10.1111/ecc.13253
    By:
    • Ciruelos, Eva M.;
    • Montaño, Alvaro;
    • Rodríguez, César A.;
    • González‐Flores, Encarnación;
    • Lluch, Ana;
    • Garrigós, Laia;
    • Quiroga, Vanesa;
    • Antón, Antonio;
    • Malón, Diego;
    • Chacón, Jose I.;
    • Velasco, Montserrat;
    • Gonzalez‐Cortijo, Lucía;
    • Jolis, Laura;
    • Echarri, María J.;
    • Muñoz, Montse;
    • Pascual, Tomás;
    • Amigo, Yolanda;
    • Casas, Maribel;
    • Carrasco, Eva;
    • Casas, Ana
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Issue Information.

    Published in:
    European Journal of Cancer Care, 2020, v. 29, n. 4, p. 1, doi. 10.1111/ecc.13106
    Publication type:
    Article